Cargando…
Retrospective Approach to Evaluate Interferences in Immunoassay
BACKGROUND: Despite the increase in sensitivity and specificity of immunoassay technique over years, analytical interference remains to be major area of concern. The interfering substances are endogenous substances that are natural, polyreactive antibodies as heterophilic or auto antibodies, or huma...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655638/ https://www.ncbi.nlm.nih.gov/pubmed/29075172 |
_version_ | 1783273571819192320 |
---|---|
author | Warade, Jayesh |
author_facet | Warade, Jayesh |
author_sort | Warade, Jayesh |
collection | PubMed |
description | BACKGROUND: Despite the increase in sensitivity and specificity of immunoassay technique over years, analytical interference remains to be major area of concern. The interfering substances are endogenous substances that are natural, polyreactive antibodies as heterophilic or auto antibodies, or human anti-animal antibodies together with other unsuspected binding proteins that are unique to the individual. Interfering substances can interfere with the reaction between analyte and reagent antibodies in immunoassay resulting in false positive or negative values. This ultimately results in misinterpretation of patients reports and finally to wrong course of treatment. OBJECTIVE: In our study, we used a retrospective approach to find out the extent of interferences and type of interferences in some cases during our routine practice. METHOD: The immunoassay reports which were clinically not correlating were retrospectively evaluated after discussion with the clinician. Over a period of six month a total of 42 samples were evaluated for interference for different immunoassay parameters such as Beta HCG, Estradiol, CA 125, AFP, prolactin, Hepatitis B Surface antigen (HbSAg) and troponin I. The samples were treated with commercially available antibody blocking agents and were reanalyzed. Commercially available diluents were used in some cases to evaluate high dose hook effect. Different platform, methodology and reagents were used for re -analysis. RESULTS: Out of 42 samples, 19 were found to be affected by interferences The data obtained for interferences was as follows beta HCG - 6 samples (2 positive and 4 negative interference); estradiol - 3 samples (2 positive and 1 negative interference); CA-125-3 samples (2 positive and 1 negative interference), Alfa Feto Protein - 2 samples (2 positive interference); prolactin - 1 sample (positive interference); Hepatitis B Surface antigen - 1 samples (negative interference); troponin I - 2 samples (positive interference). CONCLUSION: Despite the use of state of the art laboratory equipments, chances of interference in immunoassay analysis resulting from endogenous substances could not be ruled out. In conclusion, thorough evaluation of all immunoassay reports should be carried out in cases of suspected interference. |
format | Online Article Text |
id | pubmed-5655638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Communications and Publications Division (CPD) of the IFCC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56556382017-10-26 Retrospective Approach to Evaluate Interferences in Immunoassay Warade, Jayesh EJIFCC Research Article BACKGROUND: Despite the increase in sensitivity and specificity of immunoassay technique over years, analytical interference remains to be major area of concern. The interfering substances are endogenous substances that are natural, polyreactive antibodies as heterophilic or auto antibodies, or human anti-animal antibodies together with other unsuspected binding proteins that are unique to the individual. Interfering substances can interfere with the reaction between analyte and reagent antibodies in immunoassay resulting in false positive or negative values. This ultimately results in misinterpretation of patients reports and finally to wrong course of treatment. OBJECTIVE: In our study, we used a retrospective approach to find out the extent of interferences and type of interferences in some cases during our routine practice. METHOD: The immunoassay reports which were clinically not correlating were retrospectively evaluated after discussion with the clinician. Over a period of six month a total of 42 samples were evaluated for interference for different immunoassay parameters such as Beta HCG, Estradiol, CA 125, AFP, prolactin, Hepatitis B Surface antigen (HbSAg) and troponin I. The samples were treated with commercially available antibody blocking agents and were reanalyzed. Commercially available diluents were used in some cases to evaluate high dose hook effect. Different platform, methodology and reagents were used for re -analysis. RESULTS: Out of 42 samples, 19 were found to be affected by interferences The data obtained for interferences was as follows beta HCG - 6 samples (2 positive and 4 negative interference); estradiol - 3 samples (2 positive and 1 negative interference); CA-125-3 samples (2 positive and 1 negative interference), Alfa Feto Protein - 2 samples (2 positive interference); prolactin - 1 sample (positive interference); Hepatitis B Surface antigen - 1 samples (negative interference); troponin I - 2 samples (positive interference). CONCLUSION: Despite the use of state of the art laboratory equipments, chances of interference in immunoassay analysis resulting from endogenous substances could not be ruled out. In conclusion, thorough evaluation of all immunoassay reports should be carried out in cases of suspected interference. The Communications and Publications Division (CPD) of the IFCC 2017-10-10 /pmc/articles/PMC5655638/ /pubmed/29075172 Text en Copyright © 2017 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Warade, Jayesh Retrospective Approach to Evaluate Interferences in Immunoassay |
title | Retrospective Approach to Evaluate Interferences in Immunoassay |
title_full | Retrospective Approach to Evaluate Interferences in Immunoassay |
title_fullStr | Retrospective Approach to Evaluate Interferences in Immunoassay |
title_full_unstemmed | Retrospective Approach to Evaluate Interferences in Immunoassay |
title_short | Retrospective Approach to Evaluate Interferences in Immunoassay |
title_sort | retrospective approach to evaluate interferences in immunoassay |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655638/ https://www.ncbi.nlm.nih.gov/pubmed/29075172 |
work_keys_str_mv | AT waradejayesh retrospectiveapproachtoevaluateinterferencesinimmunoassay |